A 51-year-old man with chronic obstructive pulmonary disease and generalized muscle weakness

New England Journal of Medicine

Volumn 336, Issue 15, 1997, Pages 1079-1088

  Sandrock Jr , A W ^a   Cros, D P ^a   Louis, D N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CIMETIDINE; HALOPERIDOL; IPRATROPIUM BROMIDE; LORAZEPAM; METHYLPREDNISOLONE; PREDNISONE; SALBUTAMOL; THEOPHYLLINE;

ADULT; ALCOHOLISM; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEVER; HUMAN; LUNG ASPERGILLOSIS; MALE; MYOPATHY; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0030948182     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704103361508     Document Type: Article

References (45)

1. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: F.A. Davis, 1991.
2. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
3. van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-9.
4. Sumner AJ, Saida K, Saida T, Silberberg DH, Asbury AK. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol 1982;11:469-77.
5. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-42.
6. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease? Ann Neurol 1995;37:421-3.
7. Cros D, Triggs WJ. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Muscle Nerve 1994;17:675-7.
8. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-42.
9. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-95.
10. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
11. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-2.
12. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-26.
13. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-92.
14. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-31.
15. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 1987; 110:819-41.
16. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
17. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986; 49:563-73.
18. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-8.
19. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992;102:510-4.
20. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285-92.
21. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.
22. Hirano M, Ott BR, Raps EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42:2082-7.
23. al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J. Rapidly evolving myopathy with myosin-deficiency muscle fibers. Ann Neurol 1994;35:273-9.
24. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 1996;19:516-8.
25. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991;19:1125-31.
26. Op de Coul AAW, Verheul GAM, Leyten ACM, Schellens RLLA, Teepen JLJM. Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 1991;93:27-33.
27. Desmedt JE, Borenstein S. Relationship of spontaneous fibrillation potentials to muscle fibre segmentation in human muscular dystrophy. Nature 1975;258:531-4.
28. Hall ZW, Sanes JR. Synaptic structure and development: the neuromuscular junction. Cell 1993;72:Suppl:99-121.
29. Froehner SC. Regulation of ion channel distribution at synapses. Annu Rev Neurosci 1993;16:347-68.
30. Apel ED, Roberds SL, Campbell KP, Merlie JP. Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 1995;15:115-26.
31. Srinivasan Y, Elmer L, Davis J, Bennett V, Angelides K. Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature 1988;333:177-80.
32. Cannon SC, Brown RH Jr, Corey DP. A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation. Neuron 1991;6:619-26.
33. Streib EW. Evoked response testing in myotonic syndromes. Muscle Nerve 1984;7:590-2.
34. McManis PG, Lambert EH, Daube JR. The exercise test in periodic paralysis. Muscle Nerve 1986;9:704-10.
35. de Silva SM, Kuncl RW, Griffin JW, Comblath DR, Chavoustie S. Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family. Muscle Nerve 1990;13:21-6.
36. Chad DA, Lacomis D. Critically ill patients with newly acquired weakness: the clinicopathological spectrum. Ann Neurol 1994;35:257-9.
37. Zochodne DW, Ramsay DA. Acute quadriplegic myopathy. Neurology 1994;44:988-9.
38. Hirano M, Raps EC, Bonilla E, Hays AP. Acute quadriplegic myopathy. Neurology 1994;44:989.
39. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992;15:1290-8.
40. DuBois DC, Almon RR. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981;4:370-3.
41. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995;274:1221-5.
42. Hall SM, Hughes RA, Atkinson PF, McColl I, Gale A. Motor nerve biopsy in severe Guillain-Barré syndrome. Ann Neurol 1992;31:441-4.
43. Hayes M, Triggs W, Cros D. Polyneuropathy with severe distal demyelination: a subset responsive to high-dose intravenous immunoglobulins. Ann Neurol 1993;34:306. abstract.
44. Brinkmeier H, Wollinsky KH, Hulser PJ, et al. The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid. Pflugers Arch 1992;421:552-7
45. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-22.